Literature DB >> 19341875

Predicting 1-year mortality after elective abdominal aortic aneurysm repair.

Adam W Beck1, Philip P Goodney, Brian W Nolan, Donald S Likosky, Jens Eldrup-Jorgensen, Jack L Cronenwett.   

Abstract

OBJECTIVE: Benefit of prophylactic abdominal aortic aneurysm (AAA) repair requires sufficient survival to overcome operative risk. Since death within 1 year of elective open or endovascular (EVAR) infrarenal AAA repair likely indicates ineffective treatment, we developed a prediction model for 1-year mortality to aid clinical decision-making.
METHODS: We used a prospective registry of 1387 consecutive patients who had undergone elective AAA repair from 2003 to 2007 by 50 surgeons from 11 hospitals in Northern New England. Cox proportional hazards were used to analyze potential risk factors for 1-year mortality, including medical comorbidities, aortic clamp site, preoperative risk factor modification (eg, beta-blockade), and aneurysm diameter.
RESULTS: Thirty-day and 1-year mortality after open repair (n = 748) was 2.3% and 5.8%, and after EVAR (n = 639) was 0.5% and 5.7%, respectively. Factors associated with death within 1-year after open repair were: age >/= 70 (P = .007; hazard ratio [HR] 2.9, 95% confidence interval [CI] 1.3-6.3), history of chronic obstructive pulmonary disease (COPD) (P < .0001; HR 3.6, 95% CI 1.9-7.0), chronic renal insufficiency (creatinine >/= 1.8) (P = .008; HR 2.8, 95% CI 1.3-6.2) and suprarenal aortic clamp site (P < .0001; HR 3.8, 95% CI 1.9-7.5). Depending on the number of risk factors present, predicted 1-year mortality after open repair varied from 1% in patients with no risk factors to 67% in patients with four risk factors. Our model demonstrated excellent correlation between observed and expected deaths (r = 0.97). For EVAR, identified risk factors for death within 1 year included a history of congestive heart failure (CHF) (P = .002; HR 3.2, 95% CI 1.6-6.5), and aneurysm diameter >/=6.5 cm (P = .04 95% CI 1.0-4.8). Depending on the number of risk factors present, predicted mortality ranged from 3.6% to 23%. A model using CHF and aneurysm diameter correlated well with actual mortality rates, with an observed to expected ratio of 0.96.
CONCLUSION: Predictors of 1-year mortality can identify patients less likely to benefit from elective AAA repair. These factors differ for open repair vs EVAR and should be considered in individual patient decision-making. Our EVAR model had less impact on 1-year survival, even if CHF and large AAA diameter were present. However, a combination of age, COPD, renal insufficiency, and need for suprarenal clamping have significant impact on 1-year mortality after open AAA repair. Consideration of these variables should assist decision-making for elective AAA repair, especially in borderline cases.

Entities:  

Mesh:

Year:  2009        PMID: 19341875     DOI: 10.1016/j.jvs.2008.10.067

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  28 in total

Review 1.  Pathophysiology and epidemiology of abdominal aortic aneurysms.

Authors:  Ian M Nordon; Robert J Hinchliffe; Ian M Loftus; Matt M Thompson
Journal:  Nat Rev Cardiol       Date:  2010-11-16       Impact factor: 32.419

2.  Elective endovascular aortic repair conversion for type Ia endoleak is not associated with increased morbidity or mortality compared with primary juxtarenal aneurysm repair.

Authors:  Salvatore T Scali; Michael M McNally; Robert J Feezor; Catherine K Chang; Alyson L Waterman; Scott A Berceli; Thomas S Huber; Adam W Beck
Journal:  J Vasc Surg       Date:  2014-03-27       Impact factor: 4.268

3.  A one-stage operation for abdominal aortic aneurysm and intraductal papillary mucinous neoplasms of the pancreas: report of a case.

Authors:  Yoshihiko Tsuji; Ikurou Kitano; Katsuhiro Sawada
Journal:  Surg Today       Date:  2012-01-26       Impact factor: 2.549

4.  Prognostic Value of Inflammatory Biomarkers in 5-Year Survival After Endovascular Repair of Abdominal Aortic Aneurysms in a Predominantly Male Cohort: Implications for Practice.

Authors:  E Lecumberri; C Ruiz-Carmona; E Mateos; A Galarza; I Subirana; A Clara
Journal:  World J Surg       Date:  2021-03-15       Impact factor: 3.352

5.  Improving the Quality of Data in Surgical Registries.

Authors:  Philip P Goodney
Journal:  JAMA Surg       Date:  2015-07       Impact factor: 14.766

6.  Gender differences in abdominal aortic aneurysm presentation, repair, and mortality in the Vascular Study Group of New England.

Authors:  Ruby C Lo; Rodney P Bensley; Allen D Hamdan; Mark Wyers; Julie E Adams; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2013-02-04       Impact factor: 4.268

7.  Critical analysis of results after chimney endovascular aortic aneurysm repair raises cause for concern.

Authors:  Salvatore T Scali; Robert J Feezor; Catherine K Chang; Alyson L Waterman; Scott A Berceli; Thomas S Huber; Adam W Beck
Journal:  J Vasc Surg       Date:  2014-05-10       Impact factor: 4.268

8.  Preoperative prediction of mortality within 1 year after elective thoracic endovascular aortic aneurysm repair.

Authors:  Salvatore T Scali; Catherine K Chang; Robert J Feezor; Philip J Hess; Thomas M Beaver; Tomas D Martin; Thomas S Huber; Adam W Beck
Journal:  J Vasc Surg       Date:  2012-07-25       Impact factor: 4.268

9.  Patient selection and perioperative outcomes are similar between targeted and nontargeted hospitals (in the National Surgical Quality Improvement Program) for abdominal aortic aneurysm repair.

Authors:  Peter A Soden; Sara L Zettervall; Klaas H J Ultee; Jeremy D Darling; John C McCallum; Allen D Hamdan; Mark C Wyers; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2016-07-25       Impact factor: 4.268

10.  'In-stock' fenestrated stent graft for the urgent repair of an abdominal aortic aneurysm.

Authors:  Sean A Crawford; Matthew G Doyle; Leonard W Tse; Graham Roche-Nagle
Journal:  BMJ Case Rep       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.